The discovery of cannabinoid receptors (CB1R, CB2R, GPR55) in the synovial tissue of middle-aged dogs provides compelling molecular evidence supporting the use of cannabinoids for treating and delaying joint diseases. The gene discussed is CNR1; the disease is arthropathy.